Budget-Savvy Guide to Micardis Online - in the UK

Concise a broad summary and quick view

• Telmisartan, commonly sold as Micardis and generics, belongs to the angiotensin II receptor blocker class and reduces vascular resistance by blocking the renin-angiotensin system.
• Typical users are adults with essential hypertension and certain high-risk patients who require cardiovascular risk reduction when an ACE inhibitor is not suitable.
• Common tablet strengths available in the UK include 20 mg and 40 mg; 80 mg tablets exist but may be less frequently stocked and could require ordering.

Telmisartan can be prescribed alone or combined with other blood pressure medicines such as thiazide-type diuretics or calcium channel blockers. Before therapy beginsexecute a review. relevant protective guidelines and ongoing supervision and monitoringlikely potential incidental effects, and known drug risk of harmful the process of interaction. For rules on supply in the UK see the legal guidelines document section.

Return to the location the very top

Uses and labeling beacons

Prescribers may use telmisartan for the following purposes:

• Lowering raised blood pressure in adults diagnosed with essential hypertension.
• Reducing the chance of major cardiovascular events in selected high-risk adults, for example those with established atherosclerotic disease or type 2 diabetes with target organ damage, particularly when ACE inhibitors are not appropriate.

Blood pressure typically starts to improve within two to four weeks, but achieving the full effect can take several weeks of regular dosing. Continue treatment unless advised otherwise by a clinician.

Head to dose guidance | Find an alternate solution options | Move to top

Cautions and reasons a drug should not be prescribed

• Pregnancy: telmisartan is contraindicated in pregnancy. If pregnancy is discovered, stop the medicine and seek medical advice immediately.
• Known allergy to telmisartan or any formulation ingredient.
• Severe liver dysfunction or cholestatic liver disease.
• Concomitant use of the direct renin inhibitor aliskiren in people with diabetes is contraindicated. Dual blockade of the renin-angiotensin system should generally be avoided because of increased risk of kidney damage, hyperkalaemia, and low blood pressure.

For additional safety protocols to consider see cautionary measures with monitoring and logging.

Go to the very top

Risk controls with ongoing the act of monitoring

Tell your prescriber or pharmacist before you begin telmisartan if any of the following apply:

• The patient has existing kidney disease, renal artery stenosis, or a recent acute kidney injury.
• Liver dysfunction or history of cholestasis.
• Heart disorders including heart failure or ischaemic heart disease.
• High blood potassium, use of potassium supplements or salt substitutes, dehydration from vomiting or diarrhoea, or heavy diuretic use.
• Concomitant medicines that act on the renin-angiotensin system.
• Previous angioedema when taking an ARB or ACE inhibitor.
• Pregnancy intentions, current pregnancy, or breastfeeding.

Telmisartan may cause dizziness, particularly after the first dose or when the dose is increased. Rise slowly from sitting or lying positions and avoid driving or operating machinery until you know how the medicine affects you. Limit alcohol to reduce the chance of excessive blood pressure reduction.

Clinicians commonly check kidney function and serum potassium shortly after starting or increasing the dose, especially in patients with risk factors. Remind healthcare professionals of telmisartan use before surgery or dental procedures.

Verify the exchange that happens when people meet outcomes | Go back to the very top

Taking pills and setting the dose instructions and safety notes safely guidance

Follow the instructions your prescriber prescribed. The notes here are general and do not replace personalised medical advice.

• Typical starting dose for most adults: 40 mg once daily.
• Dose range: 20 mg to 80 mg once daily, adjusted according to blood pressure response.
• Administration: swallow tablets whole at about the same time each day, with or without food.
• Full effect: may take a few weeks. Do not stop treatment abruptly without medical advice.

Some patients start on 20 mg (for example, those who are volume depleted or on potent diuretics). Combination therapy with a diuretic or calcium channel blocker may be used if single-agent control is insufficient. Fine tuning of dosing are usually not required for older adults but apply caution in hepatic impairment.

Home blood pressure measurements, taken consistently, can help clinicians tailor the dose. Bring records to appointments.

Return to the original page the number one spot of the page

Exchanges and online interactions connect users across distances. among medications to verify

Central points of conversational exchange to be aware of upfront include:

• Potassium-sparing diuretics (for example, spironolactone), oral potassium or salt substitutes containing potassium: risk of hyperkalaemia.
• ACE inhibitors or aliskiren: combined use increases the likelihood of kidney injury, hyperkalaemia, and hypotension. Aliskiren is contraindicated with telmisartan in people with diabetes.
• Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen: may reduce antihypertensive effect and increase renal risk, particularly in dehydrated or elderly patients.
• Thiazide or loop diuretics: may intensify first-dose blood pressure lowering and cause symptomatic dizziness.
• Lithium: potential elevation of lithium levels; monitor closely or avoid coadministration.
• Digoxin: telmisartan may affect digoxin concentrations; consider ongoing monitoring when starting or changing dose.

Always provide a full list of prescription drugs, over-the-counter medicines, and herbal supplements to the prescriber or pharmacist.

Be aware of secondary effects. | Go to the very top

Safety and probable postmarketing effects signals

Seek immediate medical attention if you experience swelling of the face, lips, tongue, or throat, severe breathing difficulty, collapse, or severe fainting.

Commonly reported reactions include:

• Mild or frequent: dizziness, experiencing headaches, tiredness, cough, back pain, nasal congestion, abdominal discomfort, nausea, diarrhoea, and muscle cramps.
• Blood pressure related: symptomatic low blood pressure, particularly in patients who are dehydrated or taking high-dose diuretics.
• Laboratory changes: raised serum potassium (hyperkalaemia) and reduced kidney function in susceptible individuals.
• Fluid retention: peripheral swelling such as ankle oedema.
• Not so common but important events: chest pain, new or worsening heart rhythm disturbances, or heart failure in high-risk people; these are often related to the underlying illness rather than a direct effect of the drug.

Report persistent or troublesome adverse outcomes to your healthcare professional. For intercommunications in a system describe exchanges between components. that increase risk, return to the interpersonal engagements in the user journey shape satisfaction. a division in the text.

Go to the tip top of the page

Other choices and brief comparisons

Other antihypertensive options include:

• Angiotensin receptor blockers (ARBs): candesartan, irbesartan, olmesartan, valsartan, and losartan. Telmisartan has a long half-life enabling once-daily dosing; losartan is frequently a low-cost choice.
• ACE inhibitors: lisinopril, enalapril, ramipril. Effective but associated with cough and rarely angioedema; contraindicated in pregnancy.
• Calcium channel blockers: amlodipine and felodipine. Often preferred in older adults and people of Black African or Caribbean heritage.
• Thiazide-type diuretics: bendroflumethiazide and indapamide. Common adjuncts when additional lowering is needed.
• Beta-blockers: atenolol and bisoprolol. Used for specific cardiac outward signs more than routine first-line hypertension control.
• Fixed-dose combinations: telmisartan plus hydrochlorothiazide (for example, combination branded products) can simplify therapy when a diuretic is required.

The optimal medicine depends on individual medical history, side-effect tolerance, blood pressure targets, and coexisting conditions. Talk through the available options by consulting your prescriber. See price comparison chart grid for indicative costs in GBP.

Navigate back to top

Private prices across the United Kingdom, indicative

Private costs vary by pharmacy, generic versus branded product, pack size, and strength. The figures below are approximate private prices for a pack of 28 tablets and do not include consultation or delivery fees.

• Generic telmisartan 20 mg, 28 tablets: approximately 2 to 5 GBP
• Generic telmisartan 40 mg, 28 tablets: approximately 3 to 7 GBP
• Generic telmisartan 80 mg, 28 tablets: approximately 4 to 8 GBP
• Brand Micardis 28 tablets: often higher, roughly 15 to 30 GBP if stocked
• Telmisartan/hydrochlorothiazide fixed-dose combo: about 5 to 12 GBP depending on strength

Indicative costs for common various options (28 tablets):

• Amlodipine 5 mg: often below 1 GBP
• Valsartan capsule 80 mg: about 2 to 5 GBP
• Candesartan, a member of the ARB family 8 mg: about 2 to 5 GBP
• Losartan 50 mg: about 1 to 3 GBP

NHS charging: in England most adults pay a per-item NHS prescription charge (check current rates as these can change). Prescriptions are generally free in Scotland, Wales, and Northern Ireland. Prepayment certificates can reduce costs for frequent users.

Check other possibilities | Go scroll to top

Preserve and handle

Store tablets below 25 C (77 F). Short excursions between 15 C and 30 C (59 F to 86 F) are usually acceptable. Keep the medicine in its original packaging to protect from moisture and keep out of sight and reach of children.

Go back to the section above the summit of the page

Dose skipped in schedule specific guidance

When you miss a dose, take it as soon as you remember, unless the next dose is due soon. If the next dose is coming up soon, skip the i did not take the dose and stay on your usual timetable. Do not compensate for a i did not take the dose by taking an extra dose.

Move to top

In she overdosed events, what to do

Symptoms of an a drug overdose case can include severe lightheadedness, fainting, or markedly low blood pressure. If an a drug overdose case is suspected, contact NHS 111 or your local emergency department promptly. Call 999 if someone is unconscious or very unwell. Take the medicine packaging with you if you attend in person.

Head back to the very top

UK law guidance on supply and use

• Regulatory classification: telmisartan (Micardis and generics) is a Prescription Only Medicine (POM) regulated by the MHRA.
• Supply requirements: a valid prescription from an appropriate prescriber (for example a GMC-registered doctor or an independent prescriber) is required. Dispensing must be carried out by a GPhC-registered pharmacy.
• Prescription validity: most POM prescriptions should be dispensed within six months of the date on the prescription in England; telmisartan is not a controlled drug.
• Electronic prescribing: NHS Electronic Prescription Service and reputable private e-prescribing platforms are widely used for legitimate supplies.
• Online pharmacies: legitimate online providers will complete a clinical assessment and will not lawfully supply without a prescription. Always take time to check. GPhC registration details before ordering.
• Emergency supply: pharmacists may provide an emergency supply of a POM in narrowly defined circumstances after assessment; not all requests will be suitable.
• Travel and import: telmisartan is not a controlled substance. Carry medicines in original packaging with a copy of the prescription or a letter from your prescriber when travelling. Confirm airline and destination rules before travel.
• Driving and machinery: do not drive or operate machinery if the medicine causes dizziness or impairs you. It is an offence to drive while impaired by medication.
• In pregnancy, ARBs are contraindicated; discontinue them if you become pregnant. Get a second opinion your clinician about contraception and breastfeeding.
• Safety reporting and disposal: notify the team about suspected potential side effects. via the MHRA Yellow Card scheme and return unwanted medicines to a pharmacy for safe disposal.

For further safe-use information revisit clear interacting as a shared activitys reduce confusion. and mitigating steps.

Navigate back to top